Exploring the feasibility and effects of technological visual training as a potential rehabilitation tool in Parkinson’s

Not Applicable

Completed

• Conditions: Parkinson's Disease; Nervous System Diseases; Parkinson disease

• Registration Number: ISRCTN46164906
• Lead Sponsor: orthumbria University

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36206239/ (added 19/10/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37319251/ Experiences (added 19/12/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-04-21
• Study Completion: 2022-11-30
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Clinical diagnosis of Parkinson’s by a movement disorder specialist according to UK brain bank criteria (Hoehn and Yahr stage I-III)
2. Aged >50 years
3. Able to walk and stand without support or assistance from another person
4. Have adequate hearing/vision capabilities to allow participation in all aspects of the study (if participant wears prescription glasses, they must be comfortable to remove these for short periods of up to 5 min at a time in order to take part in activities whilst wearing strobe glasses)
5. Stable medication for the previous 1 month and anticipated over a period of 6 months.

Exclusion Criteria

1. History of epilepsy, seizures, migraines, severe motion sickness, or sensitivity to light
2. Psychiatric co-morbidity (such as major depressive disorder as determined by a geriatric depression scale [GDS-15] score <10)
3. Clinical diagnosis of dementia or other severe cognitive impairment
4. History of stroke, traumatic brain injury, MS, or neurological disorders other than Parkinson’s disease
5. Acute lower back or lower extremity pain, peripheral neuropathy, or rheumatic and orthopaedic diseases
6. Unstable medical conditions including cardio-vascular instability in the past 6 months
7. Unable to comply with the testing protocol
8. Currently participating in another interfering research project or undergoing any interfering therapy
9. Have not had the opportunity to receive a COVID-19 vaccine (individuals may still be included in the study if they have been offered the vaccine but have declined due to personal circumstances)
10. If experiencing COVID-19 symptoms individuals will be managed as per the latest government guidelines

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 24/05/2022: <br><br>Feasibilty measures<br>Visual attention measured using the Visual Trail Making Test (TMT) Parts A and B at baseline and<br>after the intervention period.<br><br>_____<br><br>Previous primary outcome measure:<br><br>Visual attention measured using the Visual Trail Making Test (TMT) Parts A and B at baseline, 4, and 12 weeks